Boyd Peter E. 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 11, 2024
Insider Transaction Report
Form 4
Boyd Peter E.
Chief People Officer
Transactions
- Award
Common Stock
2024-03-07+86,250→ 245,998 total - Award
Non-Qualified Stock Option (right to buy)
2024-03-07+43,125→ 43,125 totalExercise: $5.68Exp: 2034-03-07→ Common Stock (43,125 underlying)
Footnotes (3)
- [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
- [F2]The original Form 4, filed on 3/9/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares for 59,532 shares owned when in fact 59,748 shares of the Issuer's common stock were owned. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an increase in the number of shares reported as beneficially owned by the reporting person by 216 shares.
- [F3]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.